Clinical Trials Logo

Filter by:
NCT ID: NCT06027229 Suspended - COVID-19 Clinical Trials

Additional Recombinant COVID-19 Humoral and Cell-Mediated Immunogenicity in Immunosuppressed Populations

Start date: November 20, 2023
Phase: Phase 2
Study type: Interventional

To determine whether providing a recombinant booster COVID-19 vaccine improves sustained humoral and cell-mediated immunogenicity against SARS-CoV-2 in immunosuppressed patients with Inflammatory Bowel Disease (IBD) and/or solid organ transplant recipients. 120 participants will be enrolled and can expect to be on study for 6 months.

NCT ID: NCT06014515 Suspended - Clinical trials for Cardiovascular Disease

Single-tracer Multiparametric PET Imaging

Start date: February 14, 2024
Phase: Early Phase 1
Study type: Interventional

The overarching goal of this project is to develop and evaluate a single-tracer multiparametric positron emission tomography (PET) imaging solution for simultaneous imaging of blood flow and glucose metabolism using 18F-fluorodeoxyglucose (FDG) alone. The investigators working hypothesis is that quantitative blood flow can be extracted from dynamic 18F-FDG PET data by use of tracer kinetic modeling, in addition to glucose metabolism that 18F-FDG is conventionally used for.

NCT ID: NCT06009926 Suspended - Clinical trials for Malignant Solid Neoplasm

Evaluation of Broccoli Seed and Sprout Extract for Detoxification of Carcinogens in Firefighters

Start date: December 4, 2023
Phase: Phase 2
Study type: Interventional

This phase II trial tests how well broccoli seed and sprout extract (BSSE) also called Avmacol extra strength (ES) works to help break down (detoxification) some of the cancer-causing chemicals (carcinogens) that firefighters are exposed to in order to help protect cells from smoke damage. Firefighters are routinely exposed to carcinogens during the course of their daily duties particularly from smoke exposure arising from active fire rescue, structural or incidental firefighting or burning, as well as flashover training. Flashover training simulator has been specifically designed for observation and recognition of fire behavior from rollover to flashover by varying fuel loading and altering ventilation. The simulator contains the fire behavior prop with smoke coming out and air being drawn in. All fires, including those in flashover training, release toxic and carcinogenic substances. These substances, many of which are known carcinogens, increase the risk of cancer in firefighters. Several studies to date have demonstrated that firefighters are at an increased risk of developing various malignancies including melanoma, multiple myeloma, acute myeloid leukemia, prostate, kidney, brain, and respiratory tract cancers among others. Broccoli extract has the potential to effectively enhance detoxification. This study may help researchers learn how BSSE can help break down chemicals that firefighters are exposed to during flashover training to help protect their cells from smoke-damage and reduce cancer risk.

NCT ID: NCT06005662 Suspended - Opioid Use Disorder Clinical Trials

Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder

BIPOD-In
Start date: April 2027
Phase: Phase 2
Study type: Interventional

This study will examine the effect of a single high dose of psilocybin therapy (30 mg) versus a very low dose (1 mg) as an adjunctive therapy to individuals undergoing standard-of-care buprenorphine treatment for Opioid use disorder (OUD). Effects of adjunctive psilocybin will be determined for longitudinal outcomes of opioid abstinence, compliance with buprenorphine maintenance, quality of life, and mood.

NCT ID: NCT05998785 Suspended - Clinical trials for Insertional Achilles Tendinopathy

Embody Insertional Achilles Tendinopathy

IAT
Start date: August 2, 2022
Phase:
Study type: Observational

The primary objective of this study is to evaluate the long-term effects on ankle/Achilles tendon pain after repair of insertional Achilles tendinopathy (IAT) augmented with TAPESTRY Biointegrative Implant.

NCT ID: NCT05935332 Suspended - Asthma Clinical Trials

Phase 2 Study to Evaluate RPT193 in Adults With Moderate to Severe T2-high Asthma

Start date: July 5, 2023
Phase: Phase 2
Study type: Interventional

Randomized, multi-center, double-blind, placebo-controlled, parallel group, proof of-concept study with RPT193 in subjects with T2-high, moderate-to-severe asthma who are partially controlled on medium or high doses of inhaled corticosteroids (ICS) in combination with long-acting beta 2 agonist (LABA).

NCT ID: NCT05910671 Suspended - Physical Inactivity Clinical Trials

Parent-Based Physical Activity Intervention for Black Families

Start date: August 2024
Phase: N/A
Study type: Interventional

This study is an 8-week parent-based physical activity intervention focusing on increasing physical activity in preschool-aged children. The participants will be randomized into two groups: control and intervention. During the 8 weeks those in the intervention group will receive weekly newsletters and have weekly phone calls with a physical activity coach. The material in weekly newsletters and focus of the phone calls will be on behavior changes related to physical activity. Parents will be encouraged to complete physical activity alone and with their child. The control group will not have any contact with study staff during the 8-week intervention and continue with normal behaviors. Physical activity levels in the parents and children will be measures before and after the intervention.

NCT ID: NCT05879614 Suspended - Clinical trials for Prader-Willi Syndrome

An Open-Label Study of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001)

PWS-001
Start date: September 1, 2023
Phase: Phase 2
Study type: Interventional

A study of the safety, tolerability and pharmacokinetics of NNZ-2591 and measures of efficacy in children and adolescents with Prader-Willi Syndrome.

NCT ID: NCT05876858 Suspended - Myofascial Pain Clinical Trials

EXPLORER Total Body PET/CT Imaging for Myofascial Pain

Start date: June 13, 2023
Phase: Early Phase 1
Study type: Interventional

The main objective of this study is to establish novel measures derived from Total-body-Positron Emission Tomography/Computed Tomography (TB-PET/CT) as quantitative biomarkers for the investigation of myofascial pain. The TB-PET/CT assessed measures are those reflective of myofascial tissue metabolism, perfusion, and fatty infiltration.

NCT ID: NCT05840250 Suspended - Diabetes Clinical Trials

Continuous Glucose Monitoring and Diabetes

Start date: May 15, 2023
Phase: N/A
Study type: Interventional

The study is a longitudinal single-arm prospective study design. Adult patients who are African American or Hispanic with type 2 diabetes mellitus will be recruited to participate in this study. The goal of the study is to determine if the use of a continuous glucose monitoring system will improve diabetes management in persons from health disparity background. The subjects will be closely monitored for the first 3 months as they utilize the continuous glucose monitor and engage in diabetes education classes. They will then be followed for an additional 3 months to determine if they are able to maintain the same glucose control as experienced for the initial 3 months.